Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Telomir Pharmaceuticals secures $1 million investment, signaling strong investor confidence.
Telomir Pharmaceuticals secured a $1 million investment at $7 per share, marking a 20% increase over its recent stock price.
This deal, involving restricted common stock without warrants, signals strong investor confidence.
Meanwhile, Scilex Holding Company is forming a joint venture for a potential new oral treatment for obesity and Alzheimer's, currently in phase 2 clinical trials.
3 Articles
Telomir Pharmaceuticals asegura una inversión de $1 millón, lo que indica una fuerte confianza del inversor.